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Executive Summary

The cesarean section (C-section) rate has risen dramatically in the past several decades
both in the United States and throughout the world. Domestically, the C-section rate has risen
from 4.5% in 1965 to 32.2% in 2014 (National Partnership for Women & Families [NPWF],
2016a). Worldwide, roughly 19% of births occur via C-Section (Betrán et al., 2016).
Concurrently, the induction rate has also increased, doubling in the United States between 1990 –
1998 (Davey & King, 2016). As of 2014, about 23% of all women had their labors induced in
the United States (NPWF, 2016b). Furthermore, the trend toward electively inducing labor is
gaining traction with patients choosing to induce labor for logistical reasons, and physician or
patient convenience (Tam, Conte, Schuler, Malang, & Roque, 2013).
There are many drugs used to induce or augment labor, oxytocin and misoprostol being
two of the most common. Labor and delivery nurses administer these drugs on a regular basis
and usually have developed biases regarding each. However, new graduate labor and delivery
nurses as well as student nurses have not had time to develop any preconceived notions and may
very well be unaware of the evidence surrounding oxytocin and misoprostol which led to the
following PICOT question: In nursing students and new graduate labor and delivery nurses (P),
how does education regarding delivery outcomes of labor inducing agents, oxytocin and
misoprostol specifically, (I) compare to no education about labor inducing agents (C) affect their
perceptions of labor experiences (O) over 3 months following education (T)?
The literature is conflicted regarding the effects oxytocin has on labor outcomes but
presents misoprostol conferring significant benefits on achieving a vaginal delivery. Presenting
the evidence to new graduate labor and delivery nurses as well as nursing students gleaned
regarding the effects oxytocin and misoprostol have on delivery outcomes gleaned from 12
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scholarly articles will hopefully educate these nurses and guide them into forming their own
opinions, based on the evidence, regarding the safety and efficacy of these labor inducing agents.
After the evidence is presented, the participants can see the actual effects oxytocin and
misoprostol have through 3 months of clinical experience. Then, the participants can engage in
meaningful dialogue about ways to optimize the labor and delivery experience using the
perceptions they have formed based on the education provided and clinical experience. Finally,
the participants can take what they have learned, bring it to their bedside care, and find
innovative ways to promote a healthy, safe delivery for both mother and baby with the hope and
possibility of reducing the C-section potential through their nursing interventions.
1. Rationale
The C-section rate has reached unacceptable levels. As of 2018, the C-section rate was
35% in Texas, which was one of the higher rates in the nation (Centers for Disease Control and
Prevention [CDC], 2018). The risks present with a C-section far outweigh those with a vaginal
delivery. A woman who delivers via C-section will have a longer hospital stay and a higher
morbidity and mortality rate (Sandall et al., 2018). Additionally, the induction rate has also risen
with oxytocin and misoprostol being 2 commonly administered agents. In fact, Saccone et al.
(2016) found that oxytocin is the preferred agent in up to 50% of inductions in developed
countries.
The literature is divided regarding the effects of oxytocin but clearly demonstrates that
misoprostol confers significant benefits on achieving a vaginal delivery which creates a
conundrum regarding best practice in labor and delivery. New graduate nurses as well as future
nurses need to be aware of the disparity and must receive education while they still have an open
mind prior to any preconceptions being formed. It is therefore important to present the evidence
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surrounding these agents to the participants in order to ignite a dialogue amongst each other, and
possibly with their preceptors, about the safety and efficacy of oxytocin and misoprostol
regarding delivery outcomes in order to for the participants to discuss innovative promote an
optimal patient experience based on the literature results presented. This is a topic worth
bringing awareness to as the C-section and induction rates have reached unacceptable levels.
Understanding the outcomes of induction methods can, hopefully, encourage new graduate labor
and delivery nurses and students to seek out further information and engage in meaningful
dialogue based on the evidence to find ways to improve quality of care and promote a safe,
vaginal delivery for both mother and baby.
1.1 Project Goals
The goal of any change project is to effect innovative, sustainable change that will
positively affect patients (Thomas, Seifert, & Joyner, 2016). Upon future project
implementation, one of the major goals of my project is to present the evidence in a meaningful
manner that will enhance the participants’ perceptions of labor experiences and stimulate a
profound dialogue amongst the participants regarding ways to optimize the labor and delivery
experience. Nurses often do not realize the effect they have on delivery outcomes and the
laboring experience. There are many nursing interventions that can be used when administering
oxytocin and misoprostol to promote a safe vaginal delivery. I want the participants of my study
to form perceptions of labor experiences based on the evidence provided and brainstorm
innovative ways to optimize labor and delivery with the ultimate goal of decreasing the
unacceptably high C-section rate while empowering women to take a greater stake in their own
healthcare decisions.
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An additional goal is to promote a spirit of inquiry among the participants. I want them
to see the conflicting evidence was well as the dilemma it presents regarding best practice in
labor and delivery. Nursing and medicine are evolving professions as new studies are being
undertaken frequently. It will be important for the participants in my project to feel empowered
to seek out current evidence in order to continually promote best practice in labor and delivery.
2. Literature Synthesis
I began my literature search in 2018 and limited my findings to within the past 5 years. I
searched the CINAHL, EMBASE, PubMed, and Cochrane databases using the key words
“labor”, “labor induction”, “oxytocin”, and “misoprostol” as well as any variations thereof. I
found many articles that included not just oxytocin and misoprostol, but various other methods
of labor induction. The project initially focused on oxytocin alone and evolved within the last
year to include misoprostol. If oxytocin and/or misoprostol showed significant results, they were
included in the articles I chose to use. I omitted any articles that did not specifically focus on at
least one of these two agents.
Tam, Conte, Schuler, Malang and Roque (2013) conducted a retrospective cohort study
of delivery outcomes in low-risk women at term undergoing elective induction with N = 848.
The purpose of the study was to determine labor outcomes of elective inductions in term, lowrisk women. The study aimed to establish criteria for elective induction of labor by comparing
successful vaginal delivery versus operative interventions. Most patients (73.7%) received
oxytocin as the primary induction agent. Most patients who received oxytocin alone resulted in a
vaginal delivery (n = 525, 75.7%). However, administering oxytocin to nulliparous women with
unfavorable cervical exams resulted in more operative deliveries (α = 0.05). In comparison,
misoprostol resulted in an increased induction length but had only 1.95% of patients deliver via
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C-section. Overall, this study suggests that oxytocin or misoprostol use during labor can
decrease the risk of a C-section on most women compared to other induction methods.
Davey and King (2016) conducted a cross-sectional analysis of descriptive studies with N
= 42,950. The purpose of the study was to examine the risk of a cesarean section following both
induction of labor and individual methods used to induce or augment labor in term, low risk
pregnancies. The aim of the study was to describe and analyze the outcomes that occur
following induction of labor in uncomplicated nulliparous pregnancies. Each method of
induction or augmentation was found to have increased odds of a C-section, with oxytocin and
prostaglandin, with or without an amniotomy, having the greatest increase. Oxytocin and
prostaglandin induction without an amniotomy resulted in relative risk ratio (RRR) = 11.83 (95%
CI 8.4,16.6), adjusted RRR = 4.06 (95% CI 2.8, 5.8) with p < 0.0001. Oxytocin and
prostaglandin induction with an amniotomy resulted in RRR = 10.19 (95% CI 8.8, 11.9),
adjusted RRR = 3.79 (95% CI 3.2, 4.5) with p < 0.0001. Results imply that minimizing the use
of elective inductions may prove beneficial in reducing the C-section rate.
Hidalgo-Lopezosa, Hidalgo-Maestre, and Rodríguez-Borrego (2016) conducted a
descriptive study with N = 338. The purpose of the study was to compare C-section rates, 5minute Apgar scores, arterial pH values of umbilical cord blood and type of neonatal
resuscitation required, between women who were and were not stimulated with oxytocin. The
aim of the study was to assess the effects of labor induction or augmentation with oxytocin on
the maternal and neonatal outcomes. They found that nulliparous women were more likely to
have a C-section after oxytocin use during labor (n = 45, crude Odds Ratio = 5.76, 95% CI 2.5513.0, p < 0.001). Multiparous women who received oxytocin also showed an increase in Csections (n = 8, crude Odds Ratio = 6.95, 95% CI 1.41-34.27, p = 0.014). The results of this
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study suggest that oxytocin increases the risk of a C-section on both nulliparous and multiparous
women. These results should be viewed with caution, though, due to the limited sample size.
Saccone et al. (2017) conducted a systematic review and meta-analysis regarding
discontinuing or continuing oxytocin once active labor has been achieved with N = 1,538. The
purpose of the study was to evaluate how cesarean delivery was affected by both discontinuing
and continuing oxytocin administration once active labor had been achieved. The aim of the
study was to evaluate both benefits and harms of oxytocin discontinuation compared with
continuing oxytocin administration after active labor has been reached. The subgroups consist of
n = 764 in the oxytocin discontinuation group and n = 774 in the group that continued oxytocin.
Saccone et al. (2017) found that women who discontinued oxytocin had a significantly lower risk
of delivering via C-section compared to the women who continued oxytocin throughout labor
(9.3% compared to 14.7%, RR 0.64, 95% CI 0.48-0.87). Results suggest that continued use
throughout labor can increase a woman’s chances of a C-section.
Aalami-Harandi, Karamali, and Moeini (2013) conducted a randomized controlled trial
exploring the safety and efficacy of oxytocin and oral misoprostol administration to induce labor
with N = 256. The purpose of the study was to assess the efficacy and safety of administering
oral misoprostol and intravenous oxytocin to induce labor in term pregnant women. The aim of
the study was to determine the safety and efficacy of 25 µg of misoprostol every 2 hours
compared to IV infusion of 10 units of oxytocin for induction of labor in term pregnant women.
The subgroups consist of n = 128 for oxytocin administration and n = 128 for oral misoprostol
administration. Aalami-Harandi et al. (2013) discovered that the oral misoprostol group
experienced a higher rate of vaginal deliveries (n = 122, 79.7%, p < 0.001) compared to the
oxytocin group (n = 79, 61.7%, p < 0.001). Furthermore, the oxytocin group showed a
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significantly higher risk of C-section delivery (n = 49, 38.3%, p < 0.001) compared to the oral
misoprostol group (n = 26, 20.3%, p < 0.001). The results express that oral misoprostol may be a
safer choice to achieve a vaginal birth.
Alfirevic et al. (2016) conducted a systematic review and network meta-analysis focusing
on an extensive variety of induction methods and labor outcomes, including the risk of a Csection with N > 100,000. The purpose of the study was to summarize findings regarding
efficacy and cost-effectiveness for methods used to induce labor at term. The aim of the study
was to compare the efficacy and cost-effectiveness of a multitude of methods to induce labor at
term. Interestingly, oxytocin in combination with artificial rupture of membranes (AROM)
demonstrated the lowest risk for not delivering vaginally within 24 hours (OR = 0.05, 95% CI
0.07-0.32). Oxytocin administration alone established a moderate risk of a C-section (OR =
0.93, 95% CI 0.75-1.14) compared to the other methods tested; titrated low-dose oral
misoprostol actually exhibited the lowest odds of a C-section (OR = 0.62, 95% CI 0.47-0.80).
Oxytocin with AROM also demonstrated a moderate risk for a C-section (OR = 0.89, 95% CI
0.57-1.34). These results suggest that it may be prudent to combine oxytocin with AROM if
oxytocin is the drug of choice to induce or augment labor but using misoprostol may be a safer
option achieve a vaginal delivery.
Hurakadli (2016) conducted a partographic comparison of 100 primigravida women
undergoing induction with oral misoprostol, vaginal misoprostol, oxytocin or spontaneous labor
with n = 25 for each group. The purpose of the study was to study the cervical progress of labor
in primiparous women in both spontaneous labor and in those undergoing induced labor with
oxytocin, oral misoprostol, and vaginal misoprostol. The aim of the study was to study the
effects oxytocin and prostaglandins have on labor outcomes in order to suggest the best agent for
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labor induction. Oxytocin had the shortest induction to delivery interval (735 + 238, p < 0.05).
However, oxytocin exhibited the highest C-section rate of the four groups with 20% delivering
via C-section while oral misoprostol showed the lowest C-section rate (4%) (p = 0.17),
suggesting that oral misoprostol would be beneficial in achieving a vaginal delivery. These
results should be viewed with caution, though, due to the small sample size.
Mikolajczyk et al. (2016) examined data based on early, middle, and late admission to
laboring units, dilation upon admission, and oxytocin administration in each stage with N =
1202. The purpose of the study was to study the underlying causes of increasing rates of Csections, specifically any association with time of admission and oxytocin use. The aim of the
study was to determine if there is an association between cervical dilation upon admission and
labor progression as well as the risk of delivering via C-section during the first and second stages
of labor. The study also aimed to determine if oxytocin influenced delivering by C-section.
Oxytocin usage was associated with an increased risk of C-sections among the total sample
(12.5% during 1st stage of labor, 6.6% during 2nd stage of labor, p < 0.0001). It also depicted
increased C-sections among women who were less than 3.5 centimeters dilated upon admission
(12.6 % during 1st stage of labor, 8.6% during second stage of labor, p = 0.0007). However, with
women who were greater than 4.5 centimeters dilated upon admission, oxytocin was not
associated with a higher risk of C-section (7.6% during 1st stage of labor, 0% during second stage
of labor, p = 0.11). These conflicting results warrant further studies on this topic.
Mishanina et al. (2014) conducted a systematic review and meta-analysis of various
induction methods, including oxytocin, with N = 31,085. The purpose of the study was to
discover whether the risk of delivering via C-section was higher after inducing labor. The aim of
the study was to compare the risk of delivering by C-section after both inducing labor and
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expectant management in order to guide clinical decision making. Mishanina et al. (2014)
discovered that oxytocin use alone did not confer any increased C-section risk (RR 1.03, 95% CI
0.83-1.23, I² 0.0%), but exhibited a significant risk when used in combination with an AROM
(RR 0.96, 95% CI 0.72-1.29, I² 0.0%). Misoprostol was associated with a significant reduction
in C-section risk (RR 0.62, 95% CI 0.48-0.81, I² 0.0%), suggesting it made be a more prudent
option to achieve a vaginal delivery. It should be noted, though, that it was not specified whether
misoprostol was given orally or inserted.
Acharya, Devkota, Bhattarai, and Acharya (2017) conducted a hospital-based
observational study regarding the effects oxytocin and misoprostol have on labor outcomes with
N = 205. The purpose of the study was to explore outcomes associated with oxytocin and
misoprostol induction of labor. The aim of the study was to discover both maternal and fetal
outcomes associated with oxytocin and misoprostol induction. The C-section rate was
comparable among oxytocin (n = 14, 28%) and misoprostol (n = 39, 28.3%). However, the Csection rate did increase when oxytocin was given after a failed misoprostol failed to induce
labor (n = 15, 88%). Finally, achieving delivery in less than 12 hours was achieved with more
frequency with oxytocin (n = 20, 43.5%) compared to misoprostol (n = 25, 18.4%). These
results suggest that oxytocin confers a quicker delivery, but neither oxytocin nor misoprostol has
any significant effect on achieving a vaginal delivery. However, these results should be viewed
with caution due to the small sample size.
Sharada, Warrier, Reddy, and Thulasi (2018) conducted a hospital-based observational
study surrounding the delivery outcomes achieved after oxytocin and misoprostol administration
for induction of labor with N = 327. The purpose of the study was to compare maternal and
neonatal outcomes after oxytocin and misoprostol administration. The aim of the study was to
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discover any differences among both maternal and neonatal outcomes after inducing labor with
either oxytocin or misoprostol after 37 weeks gestation. The C-section rate was slightly higher
with oxytocin (n = 52, 36%) compared to misoprostol (n = 60, 32.7%). The induction to delivery
interval was quicker with oxytocin administration (mean 18.4 hours standard deviation 3.2
hours) compared to misoprostol administration (19.1 hours standard deviation 2.8 hours). These
results, which should be viewed with caution due to the small sample size, suggest that oxytocin
confers a slightly increased risk on delivering via C-section but promotes a quicker induction to
delivery interval.
Wallstrom et al. (2018) conducted a retrospective cohort study focusing on delivery
outcomes after induction of labor using a variety of agents with N = 4002. The purpose of the
study was to explore the safety and effects misoprostol and other induction methods have on
delivery method, Apgar scores, cord blood pH, postpartum hemorrhage, and active time of labor.
The aim of the study was to compare delivery outcomes of several induction agents to oral
misoprostol. Most patients who received misoprostol for labor induction achieved a vaginal
delivery (n = 1367, 82%). When presented with an immature cervix, oral misoprostol portrayed
the lowest risk a C-section for both multiparous women (11%, p < 0.01) and nulliparous women
(23%, p < 0.01). Interestingly, without accounting for other factors, such as an immature cervix,
oxytocin depicted the lowest risk for a C-section (n = 28, 12%). The oxytocin results should be
viewed with caution due to not considering influential risk factors. These results strongly
suggest that misoprostol is a safe choice when trying to achieve a vaginal delivery, especially on
those women undergoing induction who present with an immature cervix.
Only 3 studies, Wallstrom et al. (2018), Tam et al. (2013), and Mikolajczyk et al. (2016),
showed oxytocin conferring a decreased C-section risk but the latter was only in women who
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were dilated greater than 4.5 cm on admission. Interestingly, Davey and King (2016) and
Mishanina et al. (2014) associated oxytocin with an increased C-section risk when combined
with AROM while Alfirevic et al. (2016) displayed a decreased risk. Furthermore, Acharya et
al. (2017) showed an increased risk of a C-section when oxytocin was given after misoprostol
failed to induce labor. Mishanina et al. (2014), Alfirevic et al. (2016), Hurakadli (2016),
Aalami-Harandi et al. (2013), Tam et al. (2013), and Wallstrom et al. (2018) all depicted
misoprostol as having a decreased risk of a C-section suggesting that it may indeed be a more
effective option to achieve a vaginal delivery.
3. Stakeholders
It will be important to involve not only those directly affected by the project, but also
those who will have a vested interest in the outcome in order to ensure a successful, sustainable
change design. The support of nursing leaders is paramount, which in this case refers to
Women’s Services Nurse Managers and the course leader for a Maternal/Child nursing course.
These leaders have a vested interest in the outcome as it will hopefully have a positive effect on
the care their nurses and students provide. Furthermore, it will be vital to engender their support
as they have an invaluable influence on strengthening quality and integration of care the nurses
and students provide (Sfantou et al., 2017).
The new graduate labor and delivery nurses and student nurses participating in the project
are debatably one of the most influential groups of stakeholders affected. These participants will
be the ones reviewing the evidence and seeing how oxytocin and misoprostol affect labor
outcomes in clinical practice. They have an entrusted interest in the education provided as it will
be their perceptions of laboring experiences that will hopefully be influenced. These participants
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can have a great impact on enhancing labor and delivery based on education and experiences
gleaned during the project.
Arguably the most important stakeholder would be labor and delivery patients. This
population served as the inspiration for and remains the driving force behind the project. One of
the major goals is to improve laboring experiences and decrease the C-section rate. Hopefully
the participants of my project will use the evidence to develop their perceptions of labor
experience and engage in meaningful dialogue amongst each other to find ways to enhance labor
and delivery for this population.
4. Planned Implementation
The actualization of the project will take about 4-5 months to complete. The first step is
to administer a survey, in the form of a Likert scale, to new graduate labor and delivery nurses
and student nurses participating in the project (Appendix A). The purpose of administering this
survey at the start of the project is to assess any initial perceptions of labor experiences the
participants have regarding the effects oxytocin and misoprostol have on labor outcomes and
experiences.
The second step is to hold an educational offering for the participants. A PowerPoint
presentation would present evidence-based information gleaned from 12 scholarly articles
presenting evidence regarding how oxytocin and misoprostol affect delivery outcomes. The
presentation will be developed and presented by myself.
The third step is to allow 3 months for clinical experience. It is important to allow
participants to see first-hand the effects oxytocin and misoprostol have on labor outcomes and
experiences. This time frame should allow enough time for each participant to have adequate
exposure to oxytocin and misoprostol administration.
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After the 3 months of clinical experience, the same Likert scale survey needs to be
administered to the participants again in order to see if their perceptions of labor experiences
have changed after they received the evidence-based education and completed clinical
experiences. This survey also needs to be administered to nurses and students who did not
participate in the project. This would provide a sufficient comparison to see if the education
provided truly had an effect.
The final step will be to guide a roundtable discussion within 1-2 weeks of survey
completion. The nurses and students can discuss their feelings amongst each other, and with their
preceptors if possible, on how their perceptions of labor experiences have changed based on the
education provided and clinical experience undertaken. The discussion can then segue into
finding ways to optimize the labor experience for their patients with the goal of a guiding a safe
delivery and healthy baby. At the end of the discussion, the participants will be asked to
complete a project evaluation tool which will assess the efficacy of the project (Appendix B).
5. Timetable/Flowchart
First, I will administer a pre-education survey, in the form of a Likert scale to all
participants. The participants will have 1 week to complete the survey. The survey will
establish a baseline in order to determine if perceptions have changed in the future after the
educational offering and subsequent clinical experience. It will take participants ~ 15 minutes to
complete the survey.
Evidence-based education regarding the effects oxytocin and misoprostol have on labor
outcomes gleaned from 12 scholarly articles will be provided by myself to the participants within
the next 2 weeks. I will offer a day presentation as well as an evening presentation to
accommodate for varying shifts. The presentation will last approximately 1.5 hours.
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The students and new graduate labor and delivery nurses will then have 3 months of
clinical experience in labor and delivery. This should provide suitable time for thorough clinical
experience both administering oxytocin and misoprostol and observing the effects of each on
delivery outcomes. During this time, the participants should be keeping in mind the evidence
provided while developing their perceptions of labor experiences after oxytocin and misoprostol
administration.
A post-education survey, also in the form of the same Likert scale as the pre-education
survey would then be administered to all participants to see if perceptions have changed after
receiving education and caring for women receiving oxytocin and misoprostol. This survey will
be administered within 1 week after the completion of clinical experience. The survey would
also be provided to students and nurses who did not receive the evidence-based education. It
will take ~15 minutes to complete the survey.
Within 1 week, I will then guide a roundtable discussion among all participants in the
project. The guided discussion will last approximately 1 hour. The goal of the guided discussion
will be to provide an opportunity for the participants to discuss how they feel oxytocin and
misoprostol affects labor experiences. The participants will also be provided an opportunity to
discuss how the educational offering and evidence provided affected their perceptions of labor
experiences. Finally, the participants would be guided to discuss how they can find and develop
inventive, realistic ways to optimize labor and delivery based on the evidence provided and their
perceptions of labor experiences. An evaluation survey, which will take less than 10 minutes to
complete, would then be provided to the participants at the end of the discussion to assess the
efficacy of the educational offering, roundtable discussion, and the project overall.
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Step 1: Pre-education Likert Scale survey
Timeline: within 1 week. It will take ~15 minutes to complete the survey.

Step 2: Evidence-based educational offering
Timeline: 2 offerings to accommodate day and night shift. Completion of
both within next 2 weeks. Educational offering will last ~ 1.5 hours.

Step 3: Clinical experience
Timeline: Next 3 months

Step 4: Post education and clinical experience Likert scale survey.
*Note: Also administer survey to non-participants
Timeline: Within 1 week. It will take ~15 minutes to complete the survey

Step 5. Guided roundtable discussion.
Timeline: Within 1 week. Discussion to last ~1 hour.

Step 6: Administer project evaluation tool to participants
Timeline: Upon conclusion of discussion. It will take ~10 minutes to complete

the tool.
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6. Planned Evaluation and Data Collection Methods
An effective evaluation plan of this project includes administering 2 surveys, allowing
time for practical clinical experience, guiding a roundtable discussion and gathering subsequent
data in order to assess the efficacy of the project. An initial pre-education survey in the form of a
Likert scale needs to be administered at the beginning of the project. In terms of the Likert scale,
multiple statements will be provided with selections of “1” being strongly disagree, “2” disagree,
“3” neutral, “4” agree, and “5” strongly agree. The survey can be administered using Google
Forms. Data, including means with standard deviations, will then be extrapolated from the
survey to include how the participants feel oxytocin and misoprostol affect labor experiences,
both positively and negatively.
After the initial survey, I will provide evidence-based education gathered from 12
scholarly articles to the same participants on the effects oxytocin and misoprostol have on labor
outcomes. Then I will allow for 3 months clinical experience where the participants will care for
women receiving oxytocin and misoprostol. During this time, the participants will hopefully use
the evidence provided to guide their perceptions while caring for women receiving these agents.
After the clinical experience, I will administer a post-survey to the participants in the
form of a Likert scale to assess their perceptions of labor experiences after the educational
offering and clinical experience. This survey will again be completed using Google Forms.
Data, including means with standard deviations, will again be extrapolated from the survey to
include how the participants currently feel oxytocin and misoprostol affect labor experiences,
both positively and negatively. Administering the survey after the educational offering and
clinical experience will provide an opportunity for a meaningful comparison of the results
against the pre-education survey. Additionally, I will administer the same post-survey to
students and new graduate labor and delivery nurses who did not receive the educational offering
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in order to compare their results to the results of those who participated in the project and assess
the effect of the educational offering.
To compare the means in the pre and post surveys a student’s t-test will be conducted
(Kim, 2015). The t-test can also be used to compare results from the participants’ post survey to
post survey results of those who did not receive the evidence-based education to determine if the
education had a noticeable effect. ANOVA can be used to assess the differences among the
means (Sawyer, n. d.). In this project, ANOVA will be used to assess the differences among the
means within both the pre and post surveys of the participants. It can also look for similarities
and differences as well as determine if the evidence provided affected their outlooks on how
these agents affect labor experiences. These results will also illustrate whether the participants’
perceptions of labor experiences have changed after receiving the educational offering and
completing clinical experience related to oxytocin and misoprostol administration.
I will then guide a roundtable discussion with detailed talking points including how the
participants feel oxytocin and misoprostol administration affects labor experiences as well as
whether the evidence provided had any effect on their perceptions. The participants will also be
prompted to discuss innovative, realistic ways to optimize labor and delivery for their patients
based on the evidence and clinical experience. Finally, I will provide a post-discussion
evaluation survey to the participants to include assessing the value of the roundtable discussion
as well as the project itself.
Data indicating a successful project would show that the evidence provided did, in fact,
guide the participants’ opinions regarding the effects oxytocin and misoprostol have on delivery
outcomes. The results would indicate evolvement of labor perceptions after providing the
evidence in an educational offering which would be indicated via comparing the pre and post
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surveys as well comparing the results against the students and nurses who did not receive the
evidence-based education. Additionally, the participants engaging in meaningful discussions at
the roundtable regarding optimizing labor experiences based on their perceptions and the
evidence would also indicate completion of a successful project.
7. Cost/Benefit Discussion
The cost of implementing the project in the future will be minimal. The only projected
cost will be to provide a light snack during the educational offering, which can be provided for
< $200. Additional supplies necessary would include a internet access, a projector, and a
meeting/conference room. I anticipate being able to borrow these items in the future free of
charge.
The benefits to the project are vast. New graduate labor and delivery nurses as well as
student nurses will be provided evidence-based education on 2 of the most common agents they
will administer in labor and delivery, oxytocin and misoprostol. The education will be provided
to them before any biases can be formed in order to allow them to form evidence-based
perceptions of labor experiences of women receiving these agents. This project will hopefully
inspire them to take an invested role in improving labor and delivery experiences throughout
their career and decreasing the C-section potential. Furthermore, it can inspire the participants to
encourage their patients to take a greater stake in their own healthcare decisions and possibly
minimize the induction rates.
Additionally, there are several possible financial benefits to the project. An
uncomplicated vaginal birth costs between $10,000 - $15,000 and an uncomplicated C-section
costs between $20,000 - $25,000 (Montañez, 2019). C-sections come with a myriad of risks and
complications that are not as prevalent with a vaginal birth, including a longer hospital stay.
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Therefore, if my participants fully engage and develop innovative ways to optimize labor and
delivery, which includes decreasing the C-section rate, then potentially hundreds of thousands of
dollars can be spared.
8. Overall Discussion/Results
The evidence is contradictory regarding the effects that oxytocin has on labor outcomes.
However, most of the literature results agree that misoprostol confers significant benefit on
achieving vaginal deliveries. That being said, nurses can only react to the agent ordered by the
physician. However, nurses and students can still use their knowledge and skills related to the
ordered agent to have a significant impact on laboring experiences. Nurses and students need to
come together to review the evidence to form educated opinions and perceptions of labor
experiences and devise pioneering ways to boost laboring experiences unique to each induction
agent administered.
Being a benchmark and not an implementation project, there are no results from the
Likert scale surveys to discuss. In the future when I can implement, I would hope to see that the
survey results reflect an enhanced perception among the participants of the effects oxytocin and
misoprostol have on labor experiences. I would also hope to see that the participants have used
the evidence provided to engage in meaningful conversations amongst each other about ways to
improve laboring experiences for expectant mothers.
9. Recommendations
Providing education on relevant evidence has shown to improve patient care and
outcomes (Black, Balneaves, Garossino, Puyat, & Qian, 2014). Therefore, after reviewing the
evidence and statistics regarding C-section rates, I recommend implementing the project in BSN
programs, specifically to obstetric students, and new graduate labor and delivery residency
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programs. I recommend presenting the project specifically to this population in order to educate
the participants prior to any deep-set beliefs regarding oxytocin and misoprostol are formed.
The next steps in order to successfully implement my project would be to gain the
support of course leaders and Women’s Services Directors. I have spoken to Theresa Rhodes,
RN, who is the course leader of Maternal/Child at Lamar University and she is receptive to the
project. In the future, I will contact nurse manager at larger, metroplex hospitals in order to
discuss the project. Nurse leaders have indispensable attributes at their disposal to promote and
enact change among the nurses they guide (Kodama & Fukahori, 2017). Having their
encouragement when not only ensure a successful implementation, but also that the project is
sustainable in the long-term future.
As a future MSN who hopes to be teaching obstetric students, I recommend
implementing my project as part of the training of every successive obstetric class. The project
provides valuable evidence-based knowledge regarding oxytocin and misoprostol that the
students can carry with them throughout their clinical experience. However, it will be important
to provide the educational offering at the start of the semester in order to allow time for adequate
clinical experiences.
For my facility, I recommend implementing the project at the start of the new graduate
labor and delivery nurse residency program. Providing the education prior to any experience on
the labor and delivery floor will ensure that they have the most current evidence available before
they form their own opinions based on experiences. These new graduate nurses can then take
what they have learned, and form educated opinions based on the evidence and subsequent
clinical experience. They can also use the education provided to prompt meaningful discussions
amongst themselves and their preceptors about ways to improve delivery experiences.
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Even though this project focuses on providing education to new graduate labor and
delivery nurses and students, I feel it is important to also disseminate the evidence to my
experienced colleagues and nursing leadership as well. All too often experienced nurses get in
the mindset of knowing what is best based on their experience. While their clinical experiences
and knowledge is certainly invaluable, it is important to remember that nursing and medicine
change constantly and be open to viewing new evidence as it becomes available. Therefore I
recommend viewing the evidence I have provided with an open mind and being willing to
engage in discussions with the project participants about the study results and ways to improve
laboring patient outcomes and encourage their patients to have a voice regarding their medical
decisions surrounding labor and delivery.
Conclusion
The statistics are clear in showing that the C-section and induction rates have steadily
risen in the past several decades. The literature is divided regarding the effects that oxytocin has
on delivery outcome while depicting misoprostol conferring significant benefits on achieving a
vaginal delivery. New graduate labor and delivery nurses as well as student nurses need to use
the statistics as well as the evidence present in the literature to enhance their perceptions of labor
experiences in order to engage in meaningful conversations both amongst each other and with
their preceptors and discuss finding innovative, nursing interventions that can optimize the
birthing experience. Understanding the effects these agents have on delivery outcomes can,
hopefully, encourage nurses and students to continually seek out current evidence that will guide
them in increasing quality of care and provide a safe delivery for both mother and baby.
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Appendix A: Pre and Post Education Survey
1: Strongly Disagree
2: Disagree
3: Neutral
4: Agree
5: Strongly Agree
1. I feel oxytocin use in labor increases the occurrence of a cesarean section.
1

2

3

4

5

2. I feel misoprostol use in labor increases the occurrence of a cesarean section.
1

2

3

4

5

3. I feel oxytocin use in labor increases the occurrence of a vaginal delivery.
1

2

3

4

5

4. I feel misoprostol use in labor increases the occurrence of a vaginal delivery.
1

2

3

4

5

5. I feel oxytocin use in labor positively affects labor experiences.
1

2

3

4

5
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6. I feel misoprostol use in labor positively affects labor experiences.
1

2

3

4

5

7. I feel oxytocin use in labor negatively affects labor experiences.
1

2

3

4

5

8. I feel misoprostol use in labor negatively affects labor experiences.
1

2

3

4

5
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Appendix B: Project Evaluation Tool

1: Strongly Disagree
2: Disagree
3: Neutral
4: Agree
5: Strongly Agree.
1. The objectives of the project were clearly stated.
1

2

3

4

5

2. The educational offering was informative and met the objectives.
1

2

3

4

5

3. I learned new information from the evidence-based education about oxytocin that
impacted my perceptions of labor experiences.
1

2

3

4

5

4. I learned new information from the evidence-based education about misoprostol that
impacted my perceptions of labor experiences.
1

2

3

4

5

5. The prompts provided during the roundtable discussion were appropriate and met
objectives.
1

2

3

4

5
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6. The roundtable discussion promoted meaningful dialogue amongst colleagues
regarding perceptions of labor experiences.
1

2

3

4

5

7. The roundtable discussion promoted meaningful dialogue amongst colleagues
regarding ways to improve labor and delivery experiences.
1

2

3

4

5

8. I will continue to use the evidence provided to engage in profound dialogue with my
colleagues to find innovative ways to improve best practice in labor and delivery.
1

2

3

4

5

9. The project was beneficial to me and by extension, my patients.
1

2

3

4

5

10. The entire project was meaningful and satisfactory.
1

2

3

4

5
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Appendix C: Evaluation Table

PICOT Question: In nursing students and/or new graduate labor and delivery nurses (P), how does education regarding
delivery outcomes of labor inducing agents, oxytocin and misoprostol specifically, (I) compare to no education (C) affect their
perceptions of labor experiences (O) over 6 months following education of the intervention group (T)?
PICOT Question Type (Circle): Intervention Etiology

Diagnosis or Diagnostic Test

Prognosis/Prediction Meaning

Caveats
1) The only studies you should put in these tables are the ones that you know answer your question after you have done rapid
critical appraisal (i.e., the keeper studies)
2) Include APA reference
3) Use abbreviations & create a legend for readers & yourself
4) Keep your descriptions brief – there should be NO complete sentences
5) This evaluation is for the purpose of knowing your studies to synthesize.
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Appendix C: Continued
Citation:
(i.e.,
author(s),
date of
publication,
& title)
Author,
Year, Title

Conceptual
Framework

Design/
Method

Theoretical
basis for
study
Qualitative
Tradition

Sample/
Setting

Number,
Characteristi
cs,
Attrition rate
& why?

Major
Variables
Studied and
Their
Definitions
Independent
variables
(e.g., IV1 =
IV2 =)
Dependent
variables (e.g.,
DV = )

Acharya et
al., 2017,
Outcome of
misoprostol
and oxytocin
induction in
labour

None stated

Hospital
based
observati
onal
study

N=205 (miso
n=138, OT
n=50)
Pregnant
women > 37
weeks
gestation with
singleton
pregnancies.
Most were <
24 years old
and NW

IV: IOL miso
or OT
DV: MOD,
induction to
delivery
interval,
mat/neonatal
outcomes

Measurement of
Major Variables

Data
Analysis

Study Findings

Strength of the Evidence (i.e., level of evidence
+ quality [study strengths and weaknesses])

What scales were
used to measure
the outcome
variables (e.g.,
name of scale,
author, reliability
info [e.g.,
Cronbach
alphas])

What stats
were used
to answer
the
clinical
question
(i.e., all
stats do
not need
to be put
into the
table)

Statistical findings or
qualitative findings (i.e.,
for every statistical test
you have in the data
analysis column, you
should have a finding)

• Strengths and limitations of the study
• Risk or harm if study intervention or
findings implemented
• Feasibility of use in your practice
• Remember: level of evidence (See Melnyk
& Finout-Overholt, pp. 32-33) + quality of
evidence = strength of evidence & confidence
to act
• Use the USPSTF grading schema
http://www.ahrq.gov/clinic/3rduspstf/ratings.h
tm

None stated

Percentages

Most women achieved
SVD (n=138, 67.3%)

Strengths: included MW and NW, accounted for
OT after IOL miso failure, accounted for IOL
indication, described reason for C/S
Limitations: not randomized, small sample size,
does not account for comorbidities
Risk: changing protocol regarding OT after IOL
miso failure when it might be necessary
Feasibility: low-moderately feasible to
implement changes. Highly feasible to encourage
further studies
USPSTF: moderate level of certainty, grade C
Level of evidence: 6

C/S rates were comparable
between OT (n=14, 28%)
and miso (n=39, 28.3%)
C/S rose when OT given
after IOL with miso failed
(n=15, 88%)
OT quicker IOL to delivery
time in <12h (n=20,
43.5%) compared to miso
(n=25, 18.4%)
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Sharada et
al., 2018,
Misoprostol
and oxytocin
in induction
of labor

None Stated

Hospital
based
observati
onal
study

N=327 (miso
n=183, OT
n=144)
Pregnant
women > 37
weeks
gestation with
singleton
pregnancies.
Most between
20-25 years
old

IV: IOL miso
or OT

None stated

DV: MOD,
time for
induction,
induction to
delivery, Apgar
scores, mat and
neonatal
complications

Percentages

C/S slightly higher with
OT (n=52, 36%) compared
to miso (n=60, 32.7%)
Mean,
standard
deviation

Wallstrom et
al., 2017,
Labor
induction
with orally
administered
misoprostol:
A
retrospective
cohort study

None stated

Retrospe
ctive
cohort
study

OT quicker IOL to delivery
interval (mean 18.4 h
standard deviation 3.2h)
compared to miso (19.1h
standard deviation 2.8h)
OT quicker time for onset
of labor (mean 7.2h
standard deviation 0.7h)
compared to miso (mean
12.7h standard deviation
1.2h)

AR not
identified
P.K. Das
Institute of
Medical
Sciences,
Kerala
N=4002 (miso
n=1675, OT
n=228)

Most women achieved
SVD (64.8%)

IV: method of
induction

None stated

OR, CI

IOL with immature cervix
increased C/S (OR 1.7,
95% CI, 1.5-2.1)

Percentages

IOL miso showed lowest
C/S at start of induction
with immature cervix
(n=308, 18%)

DV: C/S, cord
Pregnant
women > 34
weeks
gestation with
viable
singleton fetus
AR not
identified
Sokersjukhuse
t, Stockholm,
Sweden

blood pH at
delivery,
Apgar score
<7 after 5
minutes,
active time of
labor,
postpartum
hemorrhage

IOL oral miso showed
lowest risk of C/S overall
with immature cervix for
MW (11%, p<0.01) and
NW (23%, p<0.01)
Without considering other
factors, OT showed lowest
risk of C/S (n=28, 12%)
Majority of miso patients
had SVD (n=1367, 82%)

Strengths: included MW and NW, described
administration and titration doses for miso and
OT, accounts for side effects
Limitations: does not account for reason for IOL,
not randomized, does not account for mitigating
factors, small sample size
Risk: changing protocol regarding OT based on
an observational study, giving OT immediately
to women who are not sufficiently dilated due to
desire for quicker labor
Feasibility: low-moderately feasible to
implement changes. Highly feasible to encourage
further studies
USPSTF: moderate level of certainty, grade C
Level of evidence: 6

Strengths: The study accounted for additional
C/S risk factors, large sample size, all data was
check post delivery which will increase
reliability
Limitations: Women included were older and
more educated than the national average. There
was no randomization and the study was done in
retrospect.
Risk: choosing a specific agent without regard
for a patient's specific situation based on risk of
C/S presented in the study
Feasibility: moderately feasible to guide
induction agent selection and implementation
based on risk factors
USPSTF: High level of certainty, Grade
Level of evidence: 4
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Mishanina et
al., 2014,
Use of labour
induction and
risk a
cesarean
delivery: A
systematic
review and
meta-analysis

None stated

Systemat
ic review
and
metaanalysis

N=31,085
Pregnant
women with
viable
singleton fetus

IV: method of
induction,
placebo,
expectant
management
DV: C/S

AR not
identified
157 RCTs
included

No instruments
noted

RR, CI,
heterogene
ity

IOL with OT no increased
risk for C/S RR 1.03 (95%
CI 0.83-1.28), I² 0.0%
IOL with AROM increased
risk for C/S RR 0.96
(95%CI 0.72-1.29), I²
0.0%
IOL with miso decreased
risk for C/S RR 0.62 (95%
CI 0.48-0.81), I² 0.0

Strengths: No language or geographic restrictions
on RCTs included, accounts for numerous IOL
methods, it is a systematic review
Limitations: Blinding was not clearly reported in
half the studies, did not account for all
contributing factors to a C/S, did not account for
all reasons for induction, errors in coding may
have occurred
Risk: Contradicting results may lead to no
change regarding OT
Feasibility: moderately feasible to continue to
use OT, but limit use of AROM in combination
USPSTF: high level of certainty, grade B
Level of evidence: 1
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Appendix C: Continued
Mikolajczyk
et al., 2016,
Early versus
late
admission to
labor affects
labor
progression
and risk of
cesarean
section in
nulliparous
women

None stated

Descripti
ve
observati
onal
study

N=1202
Nulliparous
women with
singleton,
vertex
pregnancies
and
spontaneous
labor onset

IV: dilation on
admission, OT
administration

No instruments
noted

Percentages
, Chi
squared

DV: C/S, SVD,
instrumental
SVD

No association between
AUG OT and C/S in
women 0.5-1.5 cm dilated
on admission and 4.5-5.5
cm on admission (11.8%
1st stage, 5.2% second
stage, p=0.86) and (7.6%
1st stage, 0% second stage,
p=.011) respectively

AR not
identified
Military
hospital in
Hawaii

Hurakadli,
2016,
Partographic
comparison
of
spontaneous
labour with
oxytocin and
prostaglandin
induced
labour

None stated

Partogra
phic
comparis
on
(randomi
zed
controlle
d trial)

N=100
Nulliparous
women,
singleton,
vertex
presentation
AR not
identified
Location not
identified

IV: OT, oral
miso, vaginal
miso, SL
DV: IOLdelivery
interval, MOD,
mat and fetal
complications

Total sample: AUG OT
increased C/S (12.5 % 1st
stage of labor, 6.6 % 2nd
stage of labor, p<0.0001)

No instruments
noted

ANOVA,
mean,
standard
deviation
Percentages
, Chi
squared

Association between AUG
OT and C/S in women
dilated 2.5-3.5 cm on
admission (12.6% 1st
stage, 8.6% second stage,
p=0.0007)
IOL OT decreased IOLdelivery time (735+238,
F=5.56, p<0.05) compared
to vaginal miso
(1080+510, F=5.56,
p<0.05) and oral miso (803
+277, F=5.56, p<0.05)

IOL OT had highest risk of
C/S (20%, x²=12.92,
p=0.17)
IOL oral miso had lowest
risk of C/S (4%, x²=12.92,
p=0.17)
IOL vaginal miso had
lower C/S risk than OT
(8%, x²=12.92, p=0.17)

Strengths: accounts for dilation on admission, indepth analysis of risk of cesarean during labor,
homogenous database of nulliparous women
Limitations: only accounts for nulliparous
women, does not account for reason for AUG, it
is an observational study, cervical dilation is
subjective
Risk: changing protocol regarding OT based on
an observational study, giving OT immediately
to women who are not sufficiently dilated
Feasibility: low-moderately feasible to
implement OT changes. Highly feasible to
encourage further studies
USPSTF: moderate level of certainty, grade C
Level of evidence: 6

Strengths: participants were randomly allocated
to groups, accounts for indication of induction,
accounts for more than one induction method
Limitations: blinding was not done, only
accounts for nulliparous women, reason for C/S
was not accounted for, small sample size
Risk: increasing use of OT to decrease length of
labor
Feasibility: moderately feasible to regulate use of
OT for IOL on nulliparous women
USPSTF: moderate level of certainty, grade B
Level of evidence: 2
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Appendix C: Continued
Alfirevic et
al., 2016,
Methods to
induce
labour: A
systematic
review,
network
meta-analysis
and costeffectiveness
analysis

None stated

Systemat
ic review
and
network
metaanalysis

N>100,000
Pregnant
women in 3rd
trimester
AR not
identified
Liverpool
Women's
Hospital; 611
studies
included in
systematic
review from
facilities
throughout the
world

IV: method of
induction

No instruments
noted

OR, CI

DV: VD24,
C/S, UH with
FHR changes,
serious neonatal
morbidity or
death, serious
mat morbidity
or death, ID,
mat
satisfaction,
NICU
admission,
Apgar <7 at 5
minutes, cost
effectiveness

IOL OT with AROM
lowest risk for no VD24,
OR = 0.05 (95% CI 0.070.32)
IOL OT moderately high
risk for no VD24, OR =
0.20 (95% CI 0.21-1.97)
IOL OT with AROM was
medium risk for C/S OR =
0.89 (95% CI 0.57-1.34)
IOL OT medium risk for
C/S OR = 0.93 (95%CI
0.75-1.14)
IOL titrated oral miso
lowest risk for C/S OR =
0.62 (95% CI, 0.47-0.80)
IOL vaginal miso low dose
(0.70, 95% CI 0.57-0.85),
oral miso high dose (0.72,
95% CI 0.58-0.88), and
vaginal miso high dose
(0.73, 95% CI 0.59-0.88)
all had lower risk for C/S
than OT

Heterogene
ity, mean,
Standard
deviation

No results provided

Strengths: No language restrictions on RCTs
included, accounted for a multitude of IOL
methods, it was a systematic review, a variety of
outcomes were studied
Limitations: Meta-analysis was only done on 6
out of 9 outcomes, not all trials provided
important data, VD24 was underreported,
maternal mortality, severe maternal morbidity,
infant mortality rate were underreported, costeffective analysis was limited to short-term
outcomes, few trials considered patient
preference
Risk: Basing IOL methods on cost instead of
medical indications, increasing use of OT with
AROM to achieve VD24 when other methods
may be preferable to the situation
Feasibility: highly feasible to use OT with
AROM to increase VD 24; moderately feasible to
decrease C/S with OT IOL
USPSTF: high level of certainty, grade B
Level of evidence: 1
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Appendix C: Continued
AalamiHarandi et
al., 2013,
Induction of
labor with
titrated oral
misoprostol
solution
versus
oxytocin in
term
pregnancy:
randomized
controlled
trial

None stated

Randomi
zed
controlle
d trial

N=256
Miso: n=128
OT: n=128
Nulliparity,
Bishop score
about 3, mean
age about 25
AR not
identified
Gynecology
Department of
Tajrish
Hospital in
Tehran, Iran

IV: miso or OT
administration
DV: primary
outcomes:
MOD, time
from IOL to
delivery, time
from IOL to
active labor,
successful IOL
within 12, 18,
and 24 hours,
serious mat
comp (UH, UR,
PA)
Secondary
outcomes: PPH,
abnormal
changes in mat
VS, GI s/s,
neonatal status,
Apgar scores,
fetal distress,
fetal death,
admission to
the NICU

No instruments
noted

Mean,
standard
deviation

Time from IOL to active
labor was shorter in OT
group (n=114, 10.1+6.1,
p=0.002) compared to
miso (n=126, 12.9+5.4,
p=0.002)
IOL to SVD was shorter in
OT group (n=79, 13.2+7.7,
p=0.01) compared to miso
(n=122, 15.6+5.1, p=0.01)

Percentages

Miso group had higher rate
of SVD at 24 hours
(n=122, 79.9%, p<0.001)
compared to OT (n=79,
61.7%, p<0.001)
Miso SVD higher at 18
hours (n=86, 67.1%,
p=0.02) compared to OT
(n=68, 53.1%, p=0.02)
OT C/S higher (n=49,
38.3%, p<0.001) compared
to miso (n=26, 20.3%,
p<0.001)

MannWhitney U,
Chisquared, Ttest

No results given

Strengths: included 2 of the most common IOL
methods. Accounted for several clinical
characteristics. Accounted for several maternal
and neonatal outcomes. Treatment groups were
assigned randomly.
Limitations: Blinding was not done. AROM vs
SROM were not considered. Reasons for C/S
were not thoroughly explained. Dose variations
were not considered.
Risk: Increase in miso for most labor inductions
despite the patient needing a quicker delivery that
OT could affect.
Feasibility: moderately feasible to decrease OT
administration for IOL
USPSTF: moderate level of certainty, Grade B
Level of evidence: 2
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Appendix C: Continued
Saccone et
al., 2017,
Discontinuin
g oxytocin
infusion in
the active
phase of
labor

None stated

Systemat
ic
Review
and meta
analysis

N=1538
d/c OT: n=764
continue OT:
n=774
Pregnant
women 36
weeks or
greater with a
singleton in
cephalic
presentation
undergoing
IOL.
AR not
identified
1 trial from
the United
States
One trial from
Europe
Both high and
low income
countries
included

IV: OT IOL for
entire labor,
discontinue OT
during IOL
once active
labor achieved

No instruments
noted

I²

Heterogeneity ranged from
low (0%) to high (96%)
between trials; no
inconsistency in risk
estimates (0%) for CS

Mean, CI,

d/c OT longer length of
active labor (mean
difference 27.65
minutes)(95% CI 3.9451.36) compared to OT
continuation
d/c OT had lower risk of
C/S (9.3% compared to
14.7% RR 0.64, 95%CI
0.48-0.87)
d/c OT had lower risk of
uterine tachysystole (6.2%
compared to 13.1%, RR
0.53, 95% CI 0.33-0.84)

DV: cesarean
section

Percentages
,RR

Strengths: Included trials worldwide, a formal
meta-analysis was included in the systematic
review, all the trials were RCTs.
Limitations: None of the trials was large. Only
one was from the United States. There was no
subgroup analysis by parity. No trials were
identified on d/c of OT after augmentation. Trials
were different regarding OT dosing and delivery
protocol. Only three RCTs used a placebo in the
control group. Data regarding parity, cervical
ripening and admission Bishop score were
limited. Around half or greater of the included
women were nulliparous and a separate analysis
on parity was not done.
Risk: d/c OT prematurely leading to longer labors
and increased complications.
Feasibility: highly feasible to d/c OT after active
labor has been achieved.
USPSTF: high certainty that the net benefit is
moderate, grade B
Level of evidence: 1
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Appendix C: Continued
Tam et al.,
2012,
Delivery
outcomes in
women
undergoing
elective labor
induction.

None stated

Retrospe
ctive
cohort
study

N=848
SVD: n=694
C/S: n=154
AR:1159
women
identified, 848
included in
study.
Characteristics
: LR,
pregnant,
between or at
39 and 41
weeks
gestation, IOL
Setting:
Resurrection
Health
Care/St.
Joseph
Hospital,
Chicago

IV: Induction
method (Foley
bulb, AROM,
cervidil, miso,
OT)
DV: delivery
method (SVD
or C/S)

No instruments
noted

ANOVA

Significant difference
between length of
induction based on
methods

Tukey HSD

OT only method showing
decreased time

Descriptive
Statistics

OT alone results in SVD
(n=525, 75.7%) OT on
NW with unfavorable CE
resulted in more C/S (α =
0.05); miso had lowest C/S
rate (1.95%)

OR
Odds for SVD are 11x
higher with OT than Foley
bulb
Chi
Squared

IOL (p = 0.0161),
gestational age (p =
0.0550) and length of
induction (p < 0.0001) are
significantly related to the
delivery method. All used
α = 0.05 for significance.

Strengths: Large sample size with diverse
population, accounts for several induction
methods
Limitations: does not account for length of labor
before C/S, reason for C/S, fetal tolerance not
assessed
Risk: Increase in elective inductions despite no
medical necessity.
Feasibility: highly feasible to enhance induction
guidelines
USPSTF: High level of certainty, Grade B
Level of evidence: 4
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Appendix C: Continued
Davey &
King, 2016,
Caesarean
section
following
induction of
labour in
uncomplicate
d first birthsa populationbased crosssectional
analysis of
42,950 births

None stated

Descripti
ve Study

N=42,950
Most women
between 25-34
Most between
39-40 weeks
gestation with
no AUG and
had SVD
AR not
identified
Victoria,
Australia

IV: IOL and
method of
induction
DV: delivery
method

No instruments
noted

OR

IOL more likely to have
CS. 2.54 (95% CI, 2.4-2.7)
p<0.0001

Relative
Risk Ratio
and
Multinomal
logistic
regression

AUG OT 6.17 (95% CI,
5.7-6.7) adjusted 2.89
(95% CI, 2.6-3.2)
p<0.0001
AUG AROM & OT 6.51
(95% CI, 5.9-7.2) adjusted
2.55 (95% CI, 2.3-2.8)
p<0.0001
IOL OT 7.37 (95% CI, 4.412.2) adjusted 4.13 (95%
CI, 2.4-7.0) p<0.0001
IOL PG & OT 11.83 (95%
CI, 8.4-16.6) adjusted 4.06
(2.8-5.8) p<0.0001
IOL AROM & OT 3.86
(95% CI, 3.3-4.6) adjusted
1.82 (95% CI, 1.5-2.2)
p<0.0001
IOL PG& AROM&OT
10.19 (95%CI, 8.8-11.9)
adjusted 3.79 (95%CI, 3.24.5) p<0.0001

Strengths: Large sample size, accounts for several
induction methods alone and in combination.
Accounts for AUG. High level of accuracy.
Limitations: does not account for indication of
AUG, reason for C/S, and length of labor trial
prior to C/S
Risk: Increase in post-dates labors or inductions.
Larger infants leading to more operative vaginal
deliveries
Feasibility: highly feasible to decrease elective
inductions
USPSTF: High level of certainty, Grade A
Level of evidence: 6
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Appendix C: Continued
HidalgoLopezosa et
al., 2016,
Labor
stimulation
with
oxytocin:
Effects on
obstetrical
and neonatal
outcomes

None stated

Descripti
ve Study

N=338
Pregnant
women with
spontaneous
labor assisted
AR not
identified
Tertiary
hospital in
south of Spain

IV: OT
stimulation
during labor
DV: Type of
delivery (C/S,
SVD, ID)
Advanced
neonatal
resuscitation
5-minute Apgar
scores
Arterial pH
values of
umbilical cord
blood
3rd and 4th
degree vaginalperineal
lacerations

No instruments
noted

OR, Chi
squared

t-test

AUG OT NW C/S n=45,
crude OR = 5.76 (95% CI
2.55-13.0), p<0.0001,
No OT NW C/S n=8, crude
OR = 5.76 (95% CI, 2.5513.0), p<0.0001
AUG OT MW C/S n=8,
crude OR= 6.95 (95% CI
1.41-34.27), p=0.014,
No OT NW C/S n=2, crude
OR = 6.95 (95% CI, 1.4134.27), p=0.014,
AUG OT NW DOL n=5.1,
crude OR = 1.62 (95% CI,
0.95-2.29), p<0.0001
No OT NW DOL n=6.8,
crude OR = 1.62 (95% CI,
0.95-2.29), p<0.0001

Strengths: Accounts for several outcomes of
oxytocin for both mother and fetus, accounts for
both primiparous and multiparous women
Limitations: small sample size, only studies
mothers at one hospital, does not account for
reason for C/S and length of labor prior, does not
account for induction
Risk: No change in oxytocin use for inductions
Feasibility: moderately feasible to decrease
oxytocin use
USPSTF: Moderate level of certainty, Grade B
Level of evidence: 6

No results provided

Legend: AR = attrition rate, AUG = augmentation of labor, AROM = artificial rupture of membranes, CE = cervical exam, comp =
complications, C/S = cesarean section, d/c = discontinue, DP = dinoprostone, DOL = duration of labor, EBL = estimated blood loss,
EM = expectant management, FHR = fetal heart rate, GI = gastrointestinal, IOL = induction of labor, LR = low-risk, mat = maternal,
MOD = mode of delivery, miso = misoprostrol MW = multiparous women, NICU = neonatal intensive care unit, NW = nulliparous
women, OD = operative delivery, OT = oxytocin, PA = placental abruption, PG = prostaglandin, PPH = postpartum hemorrhage, SL =
spontaneous labor, SROM = spontaneous rupture of membranes, s/s = signs and symptoms, SVD = spontaneous vaginal delivery, UH
= uterine hyperstimulation, UR = uterine rupture, VD24 = vaginal delivery within 24 hours, VS = vital signs

***Prompts for each column – please do not repeat the headings, just provide the data
Used with permission, © 2007 Fineout-Overholt

